Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
Crossref DOI link: https://doi.org/10.1007/s40263-017-0447-7
Published Online: 2017-06-08
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hard, Marjie L.
Mills, Richard J.
Sadler, Brian M.
Wehr, Angela Y.
Weiden, Peter J.
von Moltke, Lisa
Funding for this research was provided by:
Alkermes, Inc.
License valid from 2017-06-08